CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today reported 2024 annual results and recent business updates. Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback